Azilsartan (medoxomil monopotassium) [CAS 863031-24-7]
Azilsartan (medoxomil monopotassium) [CAS 863031-24-7]
SKU:QM-0154582-01
Couldn't load pickup availability
Request quote or documents
![Azilsartan (medoxomil monopotassium) [CAS 863031-24-7]](http://quantimol.com/cdn/shop/files/quantimol-021.png?v=1773515276&width=1445)
Product Details
-
Description
Azilsartan medoxomil monopotassium is an orally administered angiotensin II receptor type 1 antagonist with IC50 of 0.62 nM, which used in the treatment of adults with essential hypertension. IC50 Value: 0.62 nM [2] Target: AT1 receptor in vitro: In aortic endothelial cells, azilsartan inhibited cell proliferation at concentrations as low as 1 μmol/l, whereas valsartan showed little or no antiproliferative effects at concentrations below 10 μmol/l. Antiproliferative effects of azilsartan were also observed in cells lacking AT1 receptors[1]. in vivo: Oral administration of 0.1-3 mg/kg olmesartan medoxomil reduced blood pressure; however, only the two highest doses significantly reduced blood pressure 24h after dosing. ED (25) values were 0.41 and 1.3 mg/kg for azilsartan medoxomil and olmesartan medoxomil, respectively [2]. Over a longer treatment period of 24 weeks, azilsartan medoxomil showed sustained BP-lowering efficacy, with the reduction in 24-hour mean SBP at week 24 significantly greater with azilsartan medoxomil 40 or 80 mg once daily than with valsartan 320 mg once daily. Mean reductions from baseline in mean clinic SBP and DBP as well as DBP by ABPM were also significantly greater with azilsartan medoxomil 40 or 80 mg once daily than with valsartan[3]. In 4 randomized controlled trials (3 published to date), azilsartan medoxomil/chlorthalidone 40 mg/12.5 mg and 40 mg/25 mg reduced blood pressure (BP) significantly more than comparators did, including an approximately 5-mm Hg greater BP reduction than olmesartan medoxomil/hydrochlorothiazide 40 mg/25 mg and azilsartan medoxomil/hydrochlorothiazide [4].
-
CAS Number
[863031-24-7]
-
Molecular Formula
C30H23KN4O8
-
Molecular Weight
606.62
-
Smiles
O=C(C1=C2C(N=C(OCC)N2CC3=CC=C(C4=CC=CC=C4C5=NC(O[N-]5)=O)C=C3)=CC=C1)OCC6=C(C)OC(O6)=O.[K+]
-
Target
Angiotensin Receptor
-
Isoform
AT1 Receptor
-
Purity
98
-
Solubility
DMSO : 175 mg/mL (ultrasonic)
-
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
-
Shipping Conditions
Room Temperature
-
Hazard Statement
H302, H315, H319, H335
-
Precautions
H302, H315, H319, H335
Related Products
- QM-0054857-01 α-Ketoglutaric acid (disodium dihydrate) [CAS 1282616-74-3]
- QM-0054003 δ-Hexachlorocyclohexane-13C6
- QM-0053803 γ-Linolenic acid ethyl ester-d5
- QM-0052819-01 Zolpidem phenyl-4-carboxylic acid ethyl ester-d6 [CAS 1216455-48-9]
- QM-0052711 α-D-Glucopyranoside, 2-chloro-4-nitrophenyl, 2,3,4,6-tetraacetate [CAS 153823-58-6]
- QM-0052492-01 α-D-Galactopyranose,2- (acetylamino) -2-deoxy-,1,3,4,6-tetraacetate [CAS 10385-50-9]
- QM-0051894-01 β-D-Glucopyranoside,2-bromoethyl,2,3,4,6-tetraacetate [CAS 16977-78-9]
- QM-0051893 β-D-Glucopyranoside,2-chloro-4-nitrophenyl,2,3,4,6-tetraacetate [CAS 35023-71-3]
- QM-0051820-01 β-D-Glucopyranuronic acid, methyl ester,1,2,3,4-tetrakis (2-methylpropanoate) [CAS 150607-94-6]
- QM-0051622-01 α-Ketoglutaric acid (disodium hydrate)
Other industry favorites
- QM-0054857-01 α-Ketoglutaric acid (disodium dihydrate) [CAS 1282616-74-3]
- QM-0054003 δ-Hexachlorocyclohexane-13C6
- QM-0206023-01 α-Demethylnaproxen [CAS 23981-47-7]
- QM-0203548-01 α-Acetobromo-D-xylose, 95% [CAS 3068-31-3]
- QM-0071124 β-D-Ribofuranose, 3-deoxy-3-fluoro-, 1,2-diacetate 5- (4-methylbenzoate) [CAS 1884324-98-4]
- QM-0131262 [Thr28, Nle31]-Cholecystokinin (25-33), sulfated [CAS 77568-41-3]
- QM-0023392 α-Mycolic acid, keto cis [CAS 2260795-20-6]
- QM-0022881 [R- (Z) ]-4-Amino-3-chloro-2-pen-tenedioicacid [CAS 90288-29-2]
- QM-0167516 α-D-Glucopyranoside, methyl 4-deoxy-4-fluoro,2,3,6-tribenzoate [CAS 84065-98-5]
- QM-0166583-01 β-D-Galactosyl- (1→3) -N-acetyl-D-galactosamine [CAS 3554-90-3]
Azilsartan (medoxomil monopotassium) [CAS 863031-24-7]
Azilsartan (medoxomil monopotassium) is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.